NobleSNelsonAFitzmauriceD, et al.(2015) A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with low-molecular-weight heparin in the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment19(83): 1–93.
